Resources

Eliminating malaria requires collaboration across borders, sectors, and disciplines. PATH engages partners in the public, private, and nonprofit sectors to develop, evaluate, and scale tools and strategies to defeat malaria. Our partnership model translates bold ideas into products and strategies, and leverages national capacity in the fight against malaria.

This paper discusses how nonprofits like PATH can achieve US global health and development goals through effectively harnessing the power of the private sector.

This fact sheet outlines the Advancing Maternal Immunization (AMI) collaboration, which brings together diverse stakeholders to improve infant health and survival through maternal immunization. Currently focused on respiratory syncytial virus, AMI is identifying viable pathways to enable informed decision-making and rapid launch of maternal vaccines, particularly in resource-limited settings.

This guide is designed to help country decision-makers understand the evidence around when to consider introducing Japanese Encephalitis (JE) vaccines, the potential benefits, how to incorporate JE vaccines into their country’s immunization program, and how to monitor and evaluate the vaccines after introduction. It consists of six modules, including:1. Does My Country Need JE Vaccine?2. Is JE Vaccination Cost-Effective?3. Which JE Vaccine Should My Country Use?4. How Should My Country Introduce JE Vaccine?5. Can My Country Afford a JE Vaccination Program?6. Is My Country’s JE Vaccination Program Working?The guide may be downloaded as an interactive version in its entirety, or as individual printable modules.

PATH and the University of Washington are working to refine the bag-mediated filtration system (BMFS) that collects wastewater or sewage in a bag, and passes it through a simple filter that binds Poliovirus (PV). The goal of this project is to develop, validate, and commercialize a new environmental surveillance  tool to assist in global eradication of PV.